KINGFA MEDICAL and RMG’s continued cooperation provides a competitive advantage regarding production schedule, manufacturing capacity, shipping information, warehouse services and market dynamics. RMG and KINGFA MEDICAL are able to quickly react to market
The Q1 2021 Total Revenue of $1408.55 million, compared with $860.96 million of 2020, a 63.6% increase over Q1 2020.
The Net Profit for the first quarter of 2021 was $118.97million, same period last year was $22.08 million, a 438.81% increase.
On March 30, Li Nanjing, General Manager of KINGFA; Dr.Ning Kaijun,CHO of KINGFA; Ding Min, General Manager of KINGFA MEDICAL, went to Sun Yat-sen University and SCUT to attend the donation ceremony of epidemic prevention materials.There, KINGFA made the